Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics
A review on Corona Virus Disease COVID-19, epidemiology, prevention, and anticipated therapeutic advances
Published in Chemical Biology Letters
- Bhupender S. Chhikara University of Delhi
- Brijesh Rathi University of Delhi
- Jyoti Singh M.D. University
- Poonam University of Delhi
Keywords: New Virus, SARS-Cov-2, Corona Virus, Pharmaceuticals, Medicinal Chemistry, Diagnosis, Chemical Drugs, Epidemiology, Cell Mechanism, Anti-viral drugs, Antibody Therapy, Pharmacology
The recent outbreak of Corona virus SARS-CoV-2 disease COVID-19 in the China and subsequent intermittent spread of infection to other countries has alarmed the medical and scientific community mainly because of lethal nature of this infection. Being a new virus in the category, the immediate emergency therapy is not available for the treatment of this disease, leading to widespread fear of infection and has created social issues for infected peoples. Herein, the epidemiology of COVID-19 infection, transmission characteristics of SARS-CoV-2 virus spread, effectiveness of preventive measures, coronavirus family, structural characteristics of virus, current literature advances for the diagnostics development (RT-PCR, CT-Scan, Elisa) and possible drug development based virus life cycle (Entry inhibitors, replication inhibitors, nucleoside, nucleotide, protease inhibitors, heterocyclic drugs, including biological therapeutics (monoclonal antibodies therapy, vaccine development) and herbal formulations have been reviewed. The chemical drug molecules with prospective application in the treatment of COVID-19 have been included in the discussion.
Cite as: Chhikara, B. S., Rathi, B., Singh, J., & Poonam (2020). Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics: A review on Corona Virus Disease COVID-19, epidemiology, prevention, and anticipated therapeutic advances. Chemical Biology Letters, 7(1), 63-72.
Retrieve full text from http://thesciencein.org/journal/index.php/cbl/article/view/103
This is open access article published as part of priority information sharing for emergency infection COVID-19 (CBL journal confirmed its association for the priority availability of articles related with COVID-19 infection with Open Access (The Wellcome Trust, U.K. signatories).
Readers may share this article to colleagues, via email, facebook, linkedin, researchgate networks.